Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection
Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
This trial tests the safety and effectiveness of the early use of combinations of anti-HIV
drugs in HIV-infected infants and young children in an effort to block virus growth and
preserve normal immune functions.
Various anti-HIV drug combinations need to be tested in order to find the best way to treat
infants and children who have been infected with HIV during birth.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)